Filing Details

Accession Number:
0000904454-12-000370
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-07-24 12:07:10
Reporting Period:
2012-07-24
Filing Date:
2012-07-24
Accepted Time:
2012-07-24 12:07:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1544116 Durata Therapeutics Inc. DRTX Pharmaceutical Preparations (2834) 871247903
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1465143 Dp Viii Associates, L.p. C/O Domain Associates, Llc
One Palmer Square
Princeton NJ 08542
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-07-24 16,529 $0.00 16,529 No 4 C Direct
Common Stock Acquisiton 2012-07-24 5,777 $9.00 22,306 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2012-07-24 16,529 $0.00 16,529 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
Footnotes
  1. All outstanding shares of Series A preferred stock were automatically converted into Common Stock upon the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration.